lu-st.online Community
Community
Pcrx Stock Forecast
PCRX Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Became profitable this year. Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel The small drugmaker posted record sales for its flagship drug in the first quarter. View Pacira Biosciences, Inc. PCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. View the latest PCRX share price or buy & sell Pacira BioSciences stock on NASDAQ using Lightyear. Pacira BioSciences Inc is a provider of non-opioid pain. Pacira BioSciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PCRX updated stock price target summary. Stock Price Forecast. The 9 analysts with month price forecasts for Pacira BioSciences stock have an average target of , with a low estimate of and. Pacira (PCRX) Down % Since Last Earnings Report: Can It Rebound? 1 day ago • Zacks. Markets. Will. Pacira BioSciences Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ PCRX Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Became profitable this year. Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel The small drugmaker posted record sales for its flagship drug in the first quarter. View Pacira Biosciences, Inc. PCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. View the latest PCRX share price or buy & sell Pacira BioSciences stock on NASDAQ using Lightyear. Pacira BioSciences Inc is a provider of non-opioid pain. Pacira BioSciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PCRX updated stock price target summary. Stock Price Forecast. The 9 analysts with month price forecasts for Pacira BioSciences stock have an average target of , with a low estimate of and. Pacira (PCRX) Down % Since Last Earnings Report: Can It Rebound? 1 day ago • Zacks. Markets. Will. Pacira BioSciences Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $
Pacira BioSciences (NASDAQ:PCRX) Stock, Analyst Ratings, Price Targets, Forecasts. Pacira BioSciences Inc has a consensus price target of $ based on the. Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health. Pacira Pharmaceuticals (PCRX) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Pacira BioSciences, Inc. (PCRX): Price and Financial Metrics ; 5-year, % ; YTD, % ; , % ; , % ; , %. Pacira stock down % after company announces MyoScience acquisition. Shares of Pacira Pharmaceuticals Inc. fell % in premarket trade Tuesday after the. Pacira Pharmaceuticals PCRX share price forecast & targets for Intra Day are , , on the downside, and , , on the upside. Pacira. The Pacira BioSciences stock price may drop from USD to USD. The change will be %. Will PCRX stock price grow / rise / go up? No. See. future price: according to them, PCRX price has a max estimate of USD and a min estimate of USD. Watch PCRX chart and read a more detailed Pacira. View today's Pacira Pharmaceuticals Inc stock price and latest PCRX news and analysis. Create real-time notifications to follow any changes in the live. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Pacira Pharmaceuticals to be priced at by the end of this quarter and. On average, Wall Street analysts predict that Pacira Biosciences's share price could reach $ by Aug 13, The average Pacira Biosciences stock price. According to the 9 analysts' twelve-month price targets for Pacira BioSciences, the average price target is $ The highest price target for PCRX is $ Pacira BioSciences is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on. Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel The small drugmaker posted record sales for its flagship drug in the first quarter. Pacira BioSciences Stock Forecast · Over the next 52 weeks, Pacira BioSciences has on average historically risen by % based on the past 13 years of stock. Based on analysts offering 12 month price targets for PCRX in the last 3 months. The average price target is $ with a high estimate of $39 and a low. Stock Price Forecast. The 9 analysts with month price forecasts for Pacira BioSciences stock have an average target of , with a low estimate of and. Get a real-time Pacira BioSciences, Inc. (PCRX) stock price quote with breaking news, financials, statistics, charts and more. Get Pacira Biosciences Inc (PCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. On further gains, the stock will meet resistance from the long-term Moving Average at $ On a fall, the stock will find some support from the short-term.